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Executive Summary 2008 
 
The Massachusetts STD, HIV/AIDS, and Viral Hepatitis Surveillance Report, an 
annual product of the MDPH Bureau of Infectious Disease Prevention, Response and 
Services, is an occasion to reflect upon trends in these diseases within the 
Commonwealth of Massachusetts.  In 2008: 
• Infectious syphilis (primary, secondary, and early latent syphilis) incidence 
rates continued at higher than previous levels – a trend which began in the last 
quarter of 2007 and continued through 2008.   
• Gonorrhea incidence remained stable or decreased slightly.  Gonococcal 
disease is concentrated within two major urban centers: Boston and 
Springfield. 
• Incident chlamydia infection continued to increase -- the more we screen for 
it, the more infections we find.  The question remains as to whether these 
cases are reflective of increased electronic laboratory reporting, as well as 
more access to screening with more sensitive assays for infection, which may 
still result in complications such as epididymitis, pelvic inflammatory disease, 
ectopic pregnancy, infertility, or chronic pelvic pain. 
 
As to HIV/AIDS, notable trends in 2007 included the following: 
• Newly diagnosed infections and deaths continued to decline, and only one 
new case of perinatal HIV infection was reported, but the actual number of 
persons known to be living with HIV/AIDS in Massachusetts continued to 
increase to over 17,000 in 2007 because survival continues to improve. 
• Similar to other sexually transmitted infections, blacks and Hispanics have 
higher rates of HIV infection. 
• Male with male sex remains the single largest risk factor among newly 
diagnosed HIV cases. 
 
With regard to viral hepatitis: 
• Chronic confirmed cases of hepatitis B continued to decline, a trend likely 
related to school required hepatitis B vaccination programs, many of which 
were phased in between 2002-05.   
• Improvements in surveillance led to identification of more newly diagnosed, 
confirmed hepatitis C cases.  At approximately 75 cases per 100,000 
population, hepatitis C remains one of the highest volume reportable infection. 
 
Highlighted on pages 2-21 are the trends within special populations 
disproportionally affected by STDs, HIV/AIDS, and viral hepatitis.  Health disparities 
exist across the nation, Massachusetts is no exception, and STDs, HIV/AIDS, and viral 
hepatitis disproportionally affect women, minorities (both sexual and racial/ethnic 
minorities), and youth and young adults.  Massachusetts data are reflective of a number 
of national trends.  Where we differ is in the fact that our surveillance has revealed 
increasing gaps among certain racial/ethnic and sexual minorities in reported STDs.  It 
remains to be determined whether this reflects improved access to care leading to more 
  
 
screening and identification of infection or true increases in infection within certain 
minority populations.  Improvements in reporting systems are critical for improving our 
understanding of disparities in reportable diseases.   
 
It is critical to recognize that every case report represents a sentinel event, not 
only for that person, but also for the community.  We know much about how to prevent 
transmission of disease.  Our toolbox of prevention has strategies that incorporate latex 
barriers, and contextualize their use.  Secondary preventive measures, such as screening 
for infection stops chains of transmission.  Primary prevention is possible with STD 
vaccines, such as hepatitis B vaccine and HPV vaccine.  Sexual network research 
delineates why certain communities are disproportionately affected by these infections.  
An STD reflects individual risk and also the fact that that individual is a member of a 
community with a greater burden of infection. 
 
Sexually transmitted infections, including HIV/AIDS and viral hepatitis, derive 
from a nexus of individual human behavior, clinical diagnosis and treatment, and public 
health prevention and control.  The intended audience for this annual surveillance report 
includes clinicians and the laboratory professionals who report these cases, as well as   
community organizations, local public health departments, policymakers, researchers, 
and anyone interested in the sexual health and well-being of residents of the 
Commonwealth of Massachusetts.  Feedback is welcome. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Unless otherwise noted, all incidence calculations represent crude rates. The source for 
all denominator data is the U.S. Census, 2000. All data reported are current as of 
October 2009. All information on STD cases reflect year of report. Due to prolonged 
reporting delays related to transitioning from code-based to name-based reporting of 
HIV cases, all HIV/AIDS data reflect HIV diagnosed through 2007.  
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Chlamydia Cases by Gender
Massachusetts, 1999-2008
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There were 17,434 reported chlamydia
infections in Massachusetts in 2008.  
Chlamydia infection is widely distributed in 
Massachusetts.  
Compared to 2007, the distribution of cases 
throughout the state was markedly similar 
in 2008.
Chlamydia case and incidence data by city 
and town are available online at 
www.mass.gov/dph/cdc/std
Reported cases of chlamydia infection in 
Massachusetts has doubled in the past ten 
years from 8,725 in 1999 to 17,434 in 2008. 
There was a 5% increase in the number of cases 
in 2008 compared to 2007.
Of the total reported cases in 2008, 4,841 were 
among men and 12,576 were among women.  
The greater number of chlamydia cases among 
women is partly attributable to a higher level of 
screening in women as compared to men.
• The highest incidence rates of the 
diagnosis of chlamydia infection are 
clustered in the large urban areas around 
Boston and Springfield.
• Rates in the majority of cities and towns in 
the eastern part of the the state fall into 
the 11-100 range. In the western part of 
the state the majority is the 1-10 range.
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Since 1997, the Division of STD Prevention has participated in a Centers for Disease Control 
and Prevention (CDC)-funded Infertility Prevention Project. The goal of this project is to 
reduce infertility and other health consequences of chlamydia infection through increased 
screening and treatment of women who are at higher risk for infection.
In 2008, as part of the Infertility Prevention Project, 17,372 specimens were tested for 
chlamydia infection. Test results from participating sites have yielded the following:  
INFERTILITY PREVENTION PROJECT
PERCENT POSITIVE FOR CHLAMYDIA TRACHOMATIS
SITE TYPE FEMALES MALES
School-Based Health Centers (n = 775)  
County Jails (n = 3,447)  6%
Family Planning Clinics (n = 6,803)  11%
STD Clinics (n = ,347) 7% 
5%
5%
7% 6%
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Chlamydia Incidence by Race/Ethnicity  
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Chlamydia Incidence by Age  
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In 2008, the incidence of chlamydia infection 
in Massachusetts among adolescents 
(ages 15-19) and young adults (ages 20-
24) exceeded 1,250 per 100,000.  This 
contrasts with the overall Massachusetts 
chlamydia infection rate of 274.1 per 
100,000.  
Historically, communities of color have been 
disproportionately affected by STDs.  In 2008, 
compared to whites, the incidence of reported 
chlamydia infections in Massachusetts was 19 
times higher in blacks and 14 times higher in 
Hispanics.  Disparities in the rate of chlamydia
infection in Massachusetts have grown in recent 
years.
In 2008, changes in electronic reporting of STD 
cases to MDPH resulted in an increased 
proportion of STD cases being categorized as 
Other race. Increases in the rate of STD 
infections in the Other category, with 
concomitant decreases in lack and Hispanic 
rates, may be related to shifts in electronic 
reporting rather than true shifts in incidence 
rates.
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Gonorrhea Cases by Gender
Massachusetts, 1999-2008
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increase in reported gonorrhea cases 
from 1998– 2002, followed by a 
decline from 2003– 2006. After a 10% 
increase from 2006 to 2007, there was 
a 24% decrease in gonorrhea cases 
from 2007 to 2008.  Of the 2 075 total 
cases in 2008, 1,079 were in women 
and 992 were in men.  There were 
four cases reported with unknown 
gender. 
There were 2,075 cases of 
gonorrhea reported in 
Massachusetts in 2008.  Although 
gonorrhea is widely distributed in 
Massachusetts, cases are 
concentrated in urban locations.
Gonorrhea case and incidence data 
by city and town are available online 
at www.mass.gov/dph/cdc/std
• The highest incidence rates of the 
diagnosis of gonorrhea infection are 
clustered in the large urban areas 
around Boston and Springfield.
• The highest concentration of cases 
is in the eastern part of the state.
,
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Quinolone-resistant Neisseria gonorrhoeae (QRNG) is a strain of the bacteria and may not be 
cured by standard oral antibiotic therapies. QRNG often requires more aggressive approaches 
to diagnosis and treatment.
Results from the QRNG Prevalence Monitoring Project at the MDPH William A. Hinton State 
Laboratory Institute indicate that the prevalence of QRNG continues to rise in Massachusetts. 
The proportion of QRNG among positive gonorrhea cultures increased from 13.5% in 2003 
to 24.6% in 2007. Ninety-six percent of QRNG cases were identified among men, and 78% 
of the men who tested positive for QRNG self-identified as men who have sex with men 
(MSM). 
TRENDS IN ANTIBIOTIC RESISTANT gONORRHEA
g
O
N
O
R
R
H
EAGonorrhea Incidence by Race/Ethnicity 
Massachusetts, 1999-2008
0
100
200
300
400
500
600
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
BLACK HISPANIC OTHER WHITE
Cases per 100,000
Chlamydia Incidence by Age  
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The incidence of gonorrhea in 
Massachusetts is highest among 
young adults (ages 20-24), followed 
by adolescents (ages 15-19).  
Compared to the state-wide 
incidence (32.6 per 100,000) of 
gonorrhea, the incidence was 3.3 
times higher for adolescents and 4.5
times higher for young adults. 
 
 
 
 
 
In 2008, compared to whites, the reported gonorrhea 
incidence in Massachusetts was 33.4 times higher in 
blacks and 11.3 times higher in Hispanics.
Racial and ethnic disparities in gonorrhea rates in 
Massachusetts exceed the national rate, where the 
incidence in gonorrhea is 20 times higher in blacks, and 
two times higher in Hispanics, when compared to whites.  
(Source: CDC. Sexually Transmitted Disease 
Surveillance, 2008.  Atlanta, GA: U.S. Department of 
Health and Human Services, November 2009.)
In 2008, changes in electronic reporting of STD cases to 
MDPH resulted in an increased proportion of STD cases 
being categorized as Other race. Increases in the rate of 
STD infections in the Other category, with concomitant 
decreases in Black and Hispanic rates, may be related to 
shifts in electronic reporting rather than true shifts in 
incidence rates.
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In 2008, there were 367 reported infectious 
primary, secondary, and early latent 
syphilis cases in Massachusetts, a 38% 
increase since 2007.  Although infectious 
syphilis cases have been reported in 
almost all counties, 50% of cases (182) 
were reported in Suffolk County.  
Infectious syphilis case and incidence data 
by city and town are available online at 
www.mass.gov/dph/cdc/std
• All but four of the of the counties have a 
syphilis incidence rate of less than four 
cases per 100,000 population. Dukes 
County has a rate of zero.
• Suffolk county has the highest syphilis rate 
at 27.2 cases per 100,000 population.
Infectious Syphilis Cases by Gender  
Massachusetts, 1999-2008
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# CasesIn Massachusetts, the male-to-female ratio 
of infectious syphilis cases changed from 
1.3 to 1 in 1999, to 19.4 to 1 in 2008.  This 
shift reflects an increase in the number of 
infectious syphilis cases diagnosed in men 
who have sex with men.  This trend has 
also been observed in other regions of the 
United States.
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In Massachusetts, MSM represent a higher-risk group for infectious syphilis. Of the 367 
reported infectious syphilis cases in 2008, 302 (86.5%) were in MSM. Forty-one 
percent (124/ 2) of the MSM with infectious syphilis disclosed that they were co-infected 
with HIV. Fifty-two percent (157/302) of the infectious syphilis cases in MSM were 
reported in Suffolk county. 
Transmission of syphilis can occur between men through unprotected oral and anal sex. 
Additional information and resources regarding MSM and STDs is available online at 
www.gettestedmass.org.
SYPHILIS IN MEN wHO HAVE SEX wITH MEN (MSM)
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Chlamydia Incidence by Age  
Massachusetts, 1999 - 2008
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Infectious Syphilis Incidence by Age 
Massachusetts, 1999-2008
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In contrast to chlamydia infection and 
gonorrhea, which tend to occur more 
frequently among adolescents and young 
adults, infectious syphilis is more 
commonly reported in people over age 
twenty-five years.
Infecti us Syphilis Incid nce by Rac /Ethnicity
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In 2008, compared to whites, the reported 
infectious syphilis incidence in 
Massachusetts was 5.7 times higher in 
blacks and 5.2 times higher in Hispanics.
In 2008, changes in electronic reporting of 
STD cases to MDPH resulted in an 
increased proportion of STD cases being 
categorized as Other race. 
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In 2007, there were 603 reported, newly 
diagnosed HIV infections and 261 deaths 
among people with HIV/AIDS in 
Massachusetts.
Newly diagnosed HIV infections and deaths 
among people with HIV/AIDS continue to 
decline each year, but because newly 
diagnosed infections continue to exceed 
the number of deaths annually, the 
number of people known to be living with 
HIV/AIDS in Massachusetts increased 
from 12,493 in 1999 to 17,356 in 2007. 
• Of those cities and towns where HIV 
infections were diagnosed between 2005-
2007, the majority rates of diagnosis of 
HIV infection  between 10-50 per 100,000 
population.
• There were six cities and towns with 
diagnosis of HIV infection rates of greater 
than 100 per 100,000 population, including 
Boston.
Of the 351 cities and towns in 
Massachusetts, 173 (49.3%) had at least 
one, newly diagnosed HIV infection 
reported from 2005-2007.  The majority of 
newly identified HIV infections were 
reported in large urban areas.
HIV infection case and incidence data by 
city and town are available online at 
www.mass.gov/dph/cdc/aids.  Additional 
information is available through the MDPH 
HIV/AIDS Epidemiologic Profile at the 
same weblink. 
People Living with HIV/AIDS, Diagnosed HIV Infection Cases, 
and Deaths among People with HIV/AIDS
Massachusetts, 1999-2007
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Percent Distribution of Newly Diagnosed HIV Infection by 
Gender and Race/Ethnicity
Massachusetts, 2005-2007
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Identified Mother-to-Child Transmission of HIV Infection 
By Year of Birth, Massachusetts, 1985-2007
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Introduction of anti-viral therapy to prevent perinatal transmission
Promotion of Universal Screening of Pregnant  Women
From 2005-2007, of the 2,268 newly 
diagnosed HIV infections in 
Massachusetts, 1,642 (72%) were in men 
and 626 (28%) were in women.  Most of 
the newly diagnosed HIV infections in men 
were in white men whereas the majority of 
newly diagnosed HIV infections in women 
were in black women.
From 2005-2007, the primary exposure 
modes reported among newly diagnosed 
cases of HIV infection in Massachusetts 
were male with male sex (38%), presumed 
heterosexual sex (23%), injection drug use 
(14%) and heterosexual sex (10%).
Since the mid-1990’s, Massachusetts has 
experienced a dramatic reduction in 
mother-to-child transmission of HIV 
infection, with no HIV-infected newborns 
identified in 2006  2007.  
This success is attributed to 
improvements in HIV screening during 
pregnancy and the treatment of HIV-
infected women with antiretroviral therapy.  
Percent Distribution of Newly Diagnosed HIV Infection by 
Gender and Race/Ethnicity
Massachusetts, 2005-2007
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VIRAL HEPATITIS
Confirmed Acute Hepatitis B Cases by Gender and Year 
Massachusetts, 1999-2008
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The number of confirmed cases of chronic 
hepatitis B reported to Massachusetts has 
been steadily declining since 2005. In 2008, 
220 cases were reported. This is a 78% 
decline since 2005. This trend is related to 
increasing levels of immunity against 
hepatitis B in groups at risk of infection and 
virtual universal immunization of children 
against hepatitis B
Confirmed Chronic Hepatitis B Cases by Gender and Year 
Massachusetts, 1999-2008
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Thirty five confirmed acute cases of 
hepatitis B were identified in 2008. 
Confirmation of acute infection requires 
additional information, including 
specific laboratory test result and 
symptom information. 
In 2008, 537 hepatitis B positive pregnant 
women were identified in 
Massachusetts.  As a result of 
enhanced surveillance more women 
are identified prior to birth allowing  
case management to begin early and 
prevent transmission of the virus to 
infants.  Among infants born to hepatitis 
B positive women, 98%  were 
vaccinated with hepatitis B vaccine and 
HBIG within 12 hours of birth. 
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Confirmed Chronic Hepatitis B Cases Reported in 2008 by Five Year 
Age Groups and Gender (N=219, 1 missing age)
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Due to enhanced surveillance focused on 
identifying pregnant women who are 
hepatitis B carriers, a large number of the 
hepatitis B cases identified and reported 
in 2008 were in women between the ages 
of 20 and 39 years. While efforts are 
made in identifying infection among the 
household and sexual contacts of these 
women, there are many barriers to getting 
those partners tested for evidence of 
infection.
Most newly diagnosed cases of chronic 
hepatitis B are in people living in urban, 
areas such as Boston, Worcester, and 
Springfield. 
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VIRAL HEPATITIS
Confirmed Acute Hepatitis B Cases by Gender and Year 
Massachusetts, 1999-2008
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Confirmed Chronic Hepatitis B Cases by Gender and Year 
Massachusetts, 1999-2008
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Previous analyses had suggested a 
steady decline in the number of newly 
diagnosed hepatitis C cases reported in 
Massachusetts since 2004. 
Improvements in surveillance, however, 
has been associated with an increase 
in cases reported from 2006 through 
2008. Hepatitis C remains one of the 
highest volume diseases reported in 
Massachusetts.
Rate of Newly Diagnosed, Confirmed, HCV Infection Cases by Year
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Number of confirmed acute hepatitis C cases by year
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Improvements in surveillance have also allowed 
for better identification of acute cases of 
hepatitis C. Thirteen acute cases were 
confirmed in 2008. Identification of acute 
cases requires information on hepatitis A and 
B test results, serum liver enzyme tests and 
symptoms. Over 40 cases of hepatitis C 
reported in 2008 matched the acute case 
definition, but hepatitis A or B laboratory 
results were not available rule out other viral 
hepatitis causes. Acute cases of hepatitis C 
are reported in CDC’s annual summary of 
notifiable diseases, while chronic hepatitis C 
is not.
The age distribution of hepatitis C cases 
reported in Massachusetts has 
changed  between 2002 and 2008. In 
2002 the reported cases were 
distributed in a bell shaped curve with 
the peak between the ages of 44 and 
50 years. In 2008, the reported cases 
were distributed in a bi-modal curve 
with one peak at 25 years of age and a 
second at 52 years.  
Hepatitis C Case Distribution by Age: 2002 Versus 2008
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Confirmed Chronic Hepatitis B Cases Reported in 2008 by Five Year 
Age Groups and Gender (N=219, 1 missing age)
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More cases are identified in men than in 
women in almost all age groups, 
however, the male to female ratio is 
closer in the 15 to 30 year age group 
than in the 40 to 60 year age group. 
fir  r i  titi  C  rt d in 2008 by Age and 
Gender (N=7949, excludes 1014 missing gender and 3 transgender)
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Cases of hepatitis C are reported in 
communities across Massachusetts, 
with more cases being identified in 
people living the urban areas of 
Boston, Worcester, and Springfield.
ADOLESCENTS & YOuNg ADuLTS
Compared to older adults, sexually active adolescents and young adults are at higher risk 
for acquiring STDs. This higher risk is due to a combination of behavioral, biological and 
cultural factors. The higher prevalence of STDs among adolescents also reflects multiple 
barriers to quality STD prevention services, including lack of insurance or other ability to 
pay, lack of transportation, discomfort with facilities and services designed for adults, and 
concerns about confidentiality. (Source: CDC. Sexually Transmitted Disease Surveillance, 
200 . Atlanta, GA: U.S. Department of Health and Human Services, November 200 .)
STDs IN ADOLESCENTS AND YOuNg ADuLTS
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Distribution of STDs by Age
Massachusetts, 2008
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In 2008, 68% of reported chlamydia infection 
cases, and 5 % of reported gonorrhea 
cases, were in adolescents and young 
adults (ages 15-24).
Percent Distribution of Newly Diagnosed HIV Cases in 
Adolescents and Young Adults (ages 15-24) by Race/Ethnicity
Massachusetts, 2005-2007
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From 2005-2007, reported, newly diagnosed 
HIV infections among adolescents and 
young adults in Massachusetts had the 
following racial/ethnic distribution: black 
(39%), white (30%), Hispanic (27%), and 
other (4%).
4
 SEXuAL BEHAVIORS AMONg MASSACHuSETTS HIgH SCHOOL
STuDENTS BY gENDER, 2007
AFFIRMATIVE RESPONSES
MALES FEMALES
Respondents: All students
Lifetime sexual intercourse 45.2% 43.7%
Sexual intercourse before age 13 8.6% 3.6%
Four or more lifetime sexual partners 14.1% 10.6%
Respondents: Students having sexual
intercourse in past three months
Condom use at last sexual intercourse 63.2% 59.2%
Substance use at last sexual intercourse 27.7% 21.9%
Respondents: Students ever having
sexual intercourse
Ever been or gotten someone pregnant 8.5% 10.9%
Ever been diagnosed with HIV or STD 3.3% 3.3%
Source: Youth Risk Behavior Survey: www.doe.mass.edu/cnp/hprograms/yrbs/
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Youth Risk Behavior Surveillance
Massachusetts, 1993-2007
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4 or More Partners Used Condoms at Last Sex
Taught About HIV/AIDS in School
The Youth Risk Behavior Survey (YRBS) is performed 
biennially on a national sample of 9th-12th grade 
students. A review of data provided from the 
Massachusetts YRBS over the past two decades 
indicates that three markers of risky youth sexual 
behavior (ever having had sex, first sex before age 13 
years, and 4 or more lifetime sexual partners) reached 
all-time lows in 2003 (respectively 41%, 5%, and 10%), 
and have subsequently shown increases of potential 
concern (up to 44%, 6%, and 12% in 2007). In contrast, 
two markers of protective sexual behaviors, use of 
condoms at last sex and being taught about HIV/AIDS in 
school, have shown declines from previous gains 
(respectively 61% in 2007 down from 65% in 2005, and 
89% in 2007 down from 94% in 2001).
From 2005-2007, in Massachusetts, the 
primary modes of exposure for reported, 
newly diagnosed HIV infection cases in 
adolescents and young adults were male 
with male sex (48%), presumed 
heterosexual sex (24%), heterosexual sex 
(10%), and injecting drug use (7%).
N = 206
Percent Distribution of Newly Diagnosed HIV Cases in Adolescents and Young 
Adults (Ages 15-24) by Exposure Mode
Massachusetts, 2005-2007
Presumed 
Heterosexual 
Sex
24%
No Identified 
Risk
10%
Injecting Drug 
Use
7%
MSM & IDU
1%
Heterosexual 
Sex
10%
Male Sex w/ 
Male
48%
N = 206
wOMEN
Complications of STDs are greater and more frequent among women than men due to two 
primary factors. First, biologically, women are more likely than men to become infected if 
exposed to an STD. Second, STDs are more likely to remain undetected in women, resulting 
in delayed diagnosis and treatment, and ultimately more untreated infections leading to 
complications. (Source: The Hidden Epidemic, Institute of Medicine, National Academy 
Press, Washington, D.C., 1997.)
Untreated STDs in women can lead to serious health consequences, including pelvic 
inflammatorydisease, infertility, ectopic pregnancy and cervical cancer.
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Chlamydia and Gonorrhea Cases in Females 
Massachusetts, 1999–2008
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CHLAMYDIA INFECTION GONORRHEA
# CasesUnlike gonorrhea, reported chlamydia
infection in Massachusetts is more 
common in women and has been 
increasing in the past ten years, in part 
due to increased adoption of 
recommended routine screening by 
healthcare providers.
Distribution of Reported STDs by Gender
Massachusetts, 2008
Females 
72%
Males
28%
Chlamydia Infection
N = 17,434
Females
52%
Gonorrhea
N = 2,075
Males
48%
While gonorrhea cases are almost equally 
distributed among women and men, 
women are over-represented among 
chlamydia cases by a ratio of 2.6 to 1.
The greater number of chlamydia cases in 
women is attributable to more frequent 
screening of women as compared to men.
In a study of 2,048 Massachusetts women aged 18-65 years attending STD, family 
planning, and primary care clinics for routine cervical screening, overall age- and clinic-
type adjusted prevalence of high-risk human papillomavirus (HPV)* was 19%. Prevalence 
was highest among women 14 –19 years of age. (Source: Datta et al., HPV infection and 
cervical cytology in women screened for cervical cancer in the U.S., 2003-2005. Annals of 
Internal Medicine, 148:493-500, 2008.)
*High-risk HPV types were 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 68.
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From 2005-2007, the exposure modes for 
the 1,272 newly diagnosed HIV cases 
reported in women in Massachusetts was 
attributed to presumed heterosexual sex 
(45%), heterosexual sex (23%), injecting 
drug use (18%), and pediatric exposure 
(1%).
Newly Diagnosed InfectionHIV Cases in Females 
by Exposure Mode
Massachusetts, 2005-2007
N = 1,272
Heterosexual Sex
26%
Pediatric
1%
Injection Drug 
Use
16%
No Identified 
Risk
14%
Heterosexual 
Sex
23%
Presumed 
Heterosexual 
Sex
45%
Newly Diagnosed HIV Infection Cases in Females 
by Place of Birth Massachusetts, 2005-2007
Other
45%
US dependency
10%
Unspecified
3%
USA
45%
Southeast Asia 
3%
Sub-Saharan
 Africa
49%
Caribbean Basin
33%
C&S America
10%
 N America & Europe
2%
N=626 N=282
From 2005-2007, 45% of women reported 
with diagnosed HIV infection were born 
outside of the U.S.  For men diagnosed 
from 2005-2007, only 24% were born 
outside of the U.S.
Eighty-two percent of women diagnosed 
with HIV infection, who were born outside 
of the U.S., were born in regions of the 
world where heterosexual sex is the 
predominant mode of transmission of HIV 
infection.  
RACIAL/ETHNIC DISPARITIES
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Although communities of color represent 
only 18% of the total Massachusetts 
population, these communities bear a 
disproportionate burden of STDs.  In 2008, 
43% of the reported infectious syphilis 
cases, 73% of the reported gonorrhea 
cases, and 70% of the reported chlamydia
infection cases occurred in individuals 
from communities of color.
Racial/Ethnic Distribution of the General Population 
and Among Those Diagnosed with an STD
Massachusetts, 2008 
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Newly Diagnosed HIV Infection Cases by Race/Ethnicity 
Massachusetts, 2005-2007
White 
41%
Hispanic
26%
Other/Unknown
2%
Black 
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N = 2,268
From 2005-2007, the racial/ethnic 
distribution of reported, newly diagnosed 
HIV infections in Massachusetts was as 
follows: white (41%), black (31%), 
Hispanic (26%), and other/unknown (2%).
Commuities of color have traditionally experienced higher rates of reported  
STD!s, which likely reflects limited access to quality health care, poverty, and 
higher prevalence of disease in these populations. (Source: CDC. Trends in 
Reportable Sexually Transmitted Diseases in the United States, 2005.)   
Available at http://www.cdc.gov/std/stats/trends2005.htm.       
R
AC
IA
L/
ET
H
N
IC
 D
IS
PA
R
IT
IE
S
Page 19
In Massachusetts, in 2007, the prevalence 
rate of people living with HIV/AIDS was 
highest among blacks and Hispanics.  As 
compared to whites, the rate of people 
living with HIV/AIDS was 11.5 times higher 
among blacks and 10.0 times higher 
among Hispanics.
People Living with HIV/AIDS by Race/Ethnicity
Massachusetts, 2007
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MEN wHO HAVE SEX wITH MEN
Data from several U.S. cities suggest that an increasing number of men who have sex with 
men (MSM) are acquiring STDs. Because STDs and the behaviors associated with 
(Source: CDC. Sexually Transmitted Disease Surveillance, 2008. Atlanta, GA: U.S. 
Department of Health and Human Services, November 2009.)
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acquiring them increase the likelihood of acquiring and transmitting HIV infections, the 
rise in STDs among MSM may be associated with an increase in diagnoses in MSM. 
In 2008, there were 302 infectious syphilis 
cases in men who have sex with men 
(MSM) reported in Massachusetts, of 
which, 157 (52%) were in Suffolk County.  
Infectious Syphilis Cases,
Massachusetts, 1999-2008
MSM, Presumed Heterosexual Males, Females
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In the past seven years, men who have sex with 
men accounted for the majority of infectious 
syphilis cases in Massachusetts, ranging from 
50% in 2001 to 82% in 2008.
In 2008, the racial/ethnic breakdown of reported 
infectious syphilis cases in MSM was white 
(55%), black (16%), Hispanic (18%), other (4%), 
and unknown (7%). The median age of the 
cases was 38 years,  3 years younger than that 
of the year before.
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Among males, the proportion of reported 
male HIV infection cases with male to 
male sex as the reported mode of 
exposure increased from 40% in 1999 to a 
high of 56% in 2006 then declined slightly 
to 49% in 2007.
Quinolone Resistant Neisseria Gonorrhea
Cases in MSM, Presumed Heterosexual Male, 
and Female 
Massachusetts, 2002-2008
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# CasesResults from the Quinolone Resistant 
Neisseria Gonorrhea (QRNG) Prevalence 
Project indicate a rise in quinolone-
resistant gonorrhea in MSM in 
Massachusetts.  The Project reported 7 
QRNG cases in 2002 and 37 QRNG cases 
in 2007.  In 2008, 11 QRNG cases 
reported among MSM.   
Infectious Syphilis Cases in MSM by HIV Status
Massachusetts, 1999-2008
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In 2008, 41% of the reported infectious 
syphilis cases in MSM occurred in HIV-
positive individuals.
Summary of Strengths and Limitations of Data
HIV/AIDS Case Data STD Case Data Viral Hepatitis Case Data
Description •	
	
•	 Reportable	statewide.
•	 All	licensed	healthcare	
providers	are	required	by	
law	to	report.	
•	 	 	 	 	
	 	 	 	
	 	 	 	 	
	 	 	 	
	 	 	 	 	
	 	 	
	
•		 	
	 	 	
	 	
	 	 	 	
	
•	 Reportable	statewide.
•	 All	healthcare	providers	
are	required	by	law	
to	report	nine	STDs,	
including	syphilis,	
gonorrhea,	chlamydia	
infection,	and	
lymphoma	granuloma	
venereum	
•	 	 	
	 	 	
	 	
	 	 	
	 	
	 	
•	 Reportable	statewide.
•	 All	laboratories	and	
healthcare	providers	
are	required	to	report	
laboratory	indicators	
of	hepatitis	B	and	C	
infection.
Strengths •	 Statewide	reporting,	
population-based.
•	 Risk	information	is	
available.	
•	 Completeness	of	
reporting	is	high.
•	 Comparable	with	other	
states.
•	 Statewide	reporting,	
population-based.
•	 Comparable	with	other	
states.
•	 Enhanced	reporting	
of	positive	laboratory	
results.
•	 Statewide	reporting,	
population-based.
•	 Enhanced	reporting	
of	acute	cases,	
hepatitis	B	cases	in	
child-bearing	aged	
women	and	children	
and	hepatitis	C	cases	
among	youth	ages	15-
25.
Limitations •	 Under-reporting	
(10%-15%)	hampers	
interpretation	of	 	
case	 data.
•	 	 cases	
are
	
reported	 at	 time	 of	
diagnosis	(reporting	lag).
•	 HIV	data	may	be	
incomplete	because	
some	HIV-infected	
people	may	not	have	
been	tested	or	have not	
entered	care.
•	 Under-reporting	of	up	
to	10%	of	STD	cases.
•	 Race/ethnicity	is	
missing	in	31%	of	
gonorrhea	cases	and	
37%	of	Chlamydia	
infection	cases.
•	 Reports	are	not	
received	on	those	
not	seeking	care	or	
screening.
•	 Bias	is	introduced	for	
some	STDs,	such	as	
Chlamydia	infection,	
where	screening	of	
asymptomatic	persons	
occurs	more	frequently	
in	women	than	in	men.
•	 Race	data	are	missing	
in	56%	of	confirmed	
acute	hepatitis	B	and	
80%	of	confirmed	
hepatitis	C	cases;	
ethnicity	data	are	
missing	in	58%	of	
acute	hepatitis	B	and	
75%	of	confirmed	
hepatitis	C	cases.
•	 Risk	history	data	is	
missing	in	a	majority	
of	reported	hepatitis	B	
and	C	cases.
•	 Reports	not	received	
on	those	not	seeking	
care.
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HIV/AIDS
AIDS and HIV infection
cases are reported by
name, but HIV cases
included in this report
were reported by a code
extracted from identifiers
from 1999 through 2006.
HIV/AIDS
allNot	
Collected by MDPH
Bureau of Infectious
Disease Prevention,
Response and Services,
HIV/AIDS Surveillance
Program.
Collected by MDPH
Bureau of Infectious
Disease Prevention,
Response and Services,
Division of STD
Prevention.
Collected by MDPH
Bureau of Infectious
Disease Prevention,
Response and Services,
Office of Integrated
Surveillance and
Informatics Services.
Interpreting STD, HIV/AIDS and Viral Hepatitis Data
I. HIV/AIDS Exposure Mode Definitions
The HIV/AIDS exposure mode indicates the most probable risk behavior associated with HIV infection. 
Assignment of exposure mode is done in accordance with Centers for Disease Control and Prevention 
guidelines when multiple exposure modes are reported. Following is a description of the exposure 
mode categories:
•	 MSM (Male to Male Sex): Includes men who report sexual contact with other men, and men 
who report sexual contact with both men and women.
•	 IDU (Injection Drug Use): Cases in persons who report injection drug use.
•	 MSM/IDU: Cases in men who report both injection drug use and sexual contact with other men.
•	 Heterosexual Sex: Cases in persons who report specific heterosexual sex with a person with, 
or at increased risk for, HIV infection (e.g. an injection drug user). The sub-categories for this 
mode of transmission are listed below.
•	 Heterosexual Sex w/ an Injection Drug User
•	 Heterosexual Sex w/ a person w/ HIV infection or AIDS
•	 Heterosexual Sex w/Bisexual male
•	 Other Heterosexual Sex: Includes all other sub-categories of risk, such as heterosexual 
contact with a person infected through a blood transfusion.
•	 Presumed Heterosexual: Cases in persons who report heterosexual sex but do not report 
any other personal risk nor any knowledge of specific risk in their sex partners. Presumed 
Heterosexual is an exposure mode category used by the Massachusetts HIV/AIDS Surveillance 
Program. The Centers for Disease Control and Prevention (CDC) categorizes these cases as 
No Identified Risk.
•	 Pediatric: Infection before the age of 13 years, including mother to child transmission through 
pregnancy, childbirth or breastfeeding and blood transfusions to children.
•	 NIR (No Identified Risk): Cases in persons with no reported history of exposure to HIV through 
any of the listed exposure categories.  Follow-up is conducted to determine risk for those cases 
that are initially reported without a risk identified.
II. Race/Ethnicity of STD and HIV/AIDS Cases
Race/ethnicity references to whites and blacks represent persons who are white non-Hispanic and 
black non-Hispanic, respectively. All references to Hispanic for race/ethnicity represent persons of 
Hispanic heritage regardless of race.
III. References to Newly Diagnosed HIV Infections
Newly diagnosed HIV infections/cases include all persons diagnosed with HIV in 2007, including 
those who were concurrently or subsequently diagnosed with AIDS.
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Topic Contact E-Mail Phone
Policy Development  @state.ma.us 617-983-6941
and Administration (Acting Division Director)  
Sylvie Ratelle STD/HIV  Katherine Hsu  katherine.hsu@state.ma.us 617-983-6948
Prevention Training (Medical Director)
Center  Janine Dyer janine.dyer@state.ma.us 617-983-6964
 (Coordinator)
 Jim Murphy james.murphy2@dph.state.ma.us 617-983-6577
and Epidemiology 
(Director)
 
Yuren Tang
 
yuren.tang@state.ma.us
 
617-983-6554 
 
(STD Epidemiologist)
STD Clinical Services    617-983-6950
 (Medical Director)
STD Disease Intervention Hillary Johnson hillary.johnson@state.ma.us 617-983-6951
Field Services and STD (Director of Field Services)    
Partner Notification
STD Health Education,   
Training, and Prevention 
David Goudreau
 
david.goudreau@state.ma.us 
 
617-983-6835
   
Policy, Planning,  Fukuda . @state.ma.us 617-624-5310
Resource Allocation,  (OHA Director)
Research,  Deborah Isenberg deborah.isenberg@state.ma.us 617-624-5311 
and Evaluation (Director of Research and Evaluation)     
 Thera Meehan  thera.meehan@state.ma.us 617-624-5328
 (Director of Policy and Planning)   
 Tammy Goodhue tammy.goodhue@state.ma.us 617-624-5338 
 (Director of Training and
 Health Communication)
Administration and  Bob Carr bob.carr@state.ma.us 617-624-5317
Finance, Personnel,  (Deputy Bureau Director)
Contracts and  Ceci Dunn ceci.dunn@state.ma.us 617-624-5370 
Procurement, Budget (Director of Operations)  
Consumer Office Sophie Lewis sophie.lewis@state.ma.us 617-624-5366
 (Director of Consumer Office)
 Paul Goulet paul.b.goulet@state.ma.us 617-624-5389
 (Consumer Office Coordinator)  
Prevention and Education Barry Callis barry.callis@state.ma.us 617-624-5316
 (Director of                     Prevention
 and Education)   
HIV Clinical Care, Brenda Cole  brenda.cole@state.ma.us 617-624-5333
Home-Based HIV Care, (Director of Health Services)
HIV Counseling and
Testing, Corrections-
Based HIV Services    
HIV Client Services, Linda Goldman linda.goldman@state.ma.us 617-624-5347
Case Management, (Director of Client Services)
Peer Support Services, 
Housing Support Services, 
Service Coordination 
Collaboratives 
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STD, HIV/AIDS and Viral Hepatitis Contact Information
Division of STD Prevention, HIV/AIDS Surveillance, and Ratelle STD/HIV Prevention Training Centers
Office of HIV/AIDS
Brenda Cole brenda.cole
Katherine HSU katherine.hsu@state.ma.us
(Syphilis Elimination Coordinator)
STD/HIV/AIDS Surveillance 
Betsey John betsey.john@state.ma.us
Hepatitis Programing 
 
@state.ma.us 617-983-6800
 
(Hepatitis C Coordinator)
  
Hepatitis Surveillance 
 
Franny Elson
 
franny.elson@state.ma.us
 
617-983-4382
and Epidemiology
 
(Epidemiologist)
  
shauna.onofrey@state.ma.us
 
617-983-6776
Viral Hepatitus Program
Daniel Church daniel.church
617-983-6860@state.ma.usclare.o’donoghue(Contract Manager)Clare O’Donoghue 
Shauna Onofrey (Epidemiologist)
617-983-6570 
Dawn fukudadawn
Epidemiologist
Training
Professional training to community based organizations, local public health departments, and medical providers 
can be requested and is free of charge. 
Type of Training Contact Information and website  
STD Education, STD Partner Notification,  617-983-6940
and STD Reporting www.mass.gov/dph/cdc/std  
HIV/AIDS Reporting and 617-983-6560
Surveillance Projects www.mass.gov/dph/cdc/aids  
HIV/AIDS Provider Trainings 508-752-7313
 www.mass.gov/Eeohhs2/docs/dph/aids/prov_training_calendar.pdf  
Viral Hepatitis Education 617-983-6800
 http://www.mass.gov/dph/cdc/epii/imm/imm.htm  
STD/HIV Diagnosis, Treatment, 617-983-9645
and Management www.RatellePTC.org  
Material and Clinical Toolkits
Health education materials and clinical toolkits can be requested free of charge. 
STD, HIV, Viral Hepatitis Fact Sheets  617-983-6940 or 617-624-5338
 www.mass.gov/dph/cdc/factsheets/factsheets.htm  
HIV/AIDS Reporting for Health Care 617-983-6560
Providers Brochure www.mass.gov/dph/cdc/aids/hiv_report_for_health_care_providers.htm 
Viral Hepatitis Posters and Brochures 617-983-6800
 www.mass.gov/dph/cdc/epii/hepatitis/hepa.htm or
 www.mass.gov/hepc  
STD/HIV Diagnosis, Treatment,  617-983-9645
and Management Toolkits www.  RatellePTC.org  
MDPH and MDPH Funded websites
Division of STD Prevention www.mass.gov/dph/cdc/std
HIV/AIDS Bureau www.mass.gov/dph/aids
HIV/AIDS Surveillance www.mass.gov/dph/cdc/aids
Viral Hepatitis Program   
Hepatitis C www.mass.gov/hepc
Hepatitis A www.mass.gov/dph/cdc/epii/hepatitis/hepa.htm
Sylvie Ratelle STD/HIV www.RatellePTC.org
Prevention Training Center 
GetTestedBoston (for MSM) www.gettestedboston.org
 (for ) www.STD411.org
National websites
Center for Disease Control and Prevention www.cdc.gov
Division of STD Prevention www.cdc.gov/std
Division of HIV/AIDS Prevention www.cdc.gov/hiv
Division of Viral Hepatitis www.cdc.gov/ncidod/diseases/hepatitis
National Network of STD/HIV 
www.stdhivpreventiontraining.orgPrevention Training Centers
 
STD, HIV/AIDS and Viral Hepatitis Resources
DIVISION OF STD PREVENTION AND HIV S
young adults/adultsSTD411
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